Current Issue Jan-Feb 2025; Volume 5, Issue 1

ISSUE HIGHLIGHTS

High Tumoral KPNA2 Expression Is a Potential Biomarker for Poor Prognosis in Advanced Neuroblastoma Patients
SAYAKA OTAKE
KENJIRO OGUSHI
GENDENSUREN DORJKHORLOO
TAKEHIKO YOKOBORI
AKIRA NISHI
HIROYUKI KUWANO
HIROSHI SAEKI
 and 
KEN SHIRABE
Cancer Diagnosis & Prognosis Jan-Feb; 5(1): 1-7 DOI: 10.21873/cdp.10404
Impact of C-FOS/C-JUN Transcriptional Factors Co-Expression in Non–small Cell Lung Carcinoma
KONSTANTINOS MANIOS
ARISTEIDIS CHRYSOVERGIS
VASILEIOS PAPANIKOLAOU
EVANGELOS TSIAMBAS
MARIA ADAMOPOULOU
ATHANASIOS STAMATELOPOULOS
ΚONSTANTINOS VACHLAS
SOTIRIOS PAPOULIAKOS
PAVLOS PANTOS
GEORGE AGROGIANNIS
ANDREAS C. LAZARIS
EFTHYMIOS KYRODIMOS
PERIKLIS TOMOS
 and 
NIKOLAOS KAVANTZAS
Cancer Diagnosis & Prognosis Jan-Feb; 5(1): 15-20 DOI: 10.21873/cdp.10406
Tumor β-Catenin Expression Associated With Poor Prognosis to Anti-PD-1 Antibody Monotherapy in Non-small Cell Lung Cancer
SATOSHI MUTO
YUKI OZAKI
HIKARU YAMAGUCHI
MASAYUKI WATANABE
NAOYUKI OKABE
YUKI MATSUMURA
KAZUYUKI HAMADA
 and 
HIROYUKI SUZUKI
Cancer Diagnosis & Prognosis Jan-Feb; 5(1): 32-41 DOI: 10.21873/cdp.10409
Purchase access
Email Alerts

Table of contents Jan-Feb 2025; Volume 5, Issue 1

Research articles
High Tumoral KPNA2 Expression Is a Potential Biomarker for Poor Prognosis in Advanced Neuroblastoma Patients
SAYAKA OTAKE
KENJIRO OGUSHI
GENDENSUREN DORJKHORLOO
TAKEHIKO YOKOBORI
AKIRA NISHI
HIROYUKI KUWANO
HIROSHI SAEKI
 and 
KEN SHIRABE
Cancer Diagnosis & Prognosis Jan-Feb; 5(1): 1-7 DOI: 10.21873/cdp.10404
Elevated-c-MYC-expressing Fibrosarcoma Cells With Acquired Gemcitabine Resistance Remain Sensitive to Recombinant Methioninase: A Potential Clinical Strategy for a Recalcitrant Disease
SEI MORINAGA
QINGHONG HAN
KOHEI MIZUTA
BYUNG MO KANG
MICHAEL BOUVET
NORIO YAMAMOTO
KATSUHIRO HAYASHI
HIROAKI KIMURA
SHINJI MIWA
KENTARO IGARASHI
TAKASHI HIGUCHI
HIROYUKI TSUCHIYA
SATORU DEMURA
 and 
ROBERT M. HOFFMAN
Cancer Diagnosis & Prognosis Jan-Feb; 5(1): 8-14 DOI: 10.21873/cdp.10405
Impact of C-FOS/C-JUN Transcriptional Factors Co-Expression in Non–small Cell Lung Carcinoma
KONSTANTINOS MANIOS
ARISTEIDIS CHRYSOVERGIS
VASILEIOS PAPANIKOLAOU
EVANGELOS TSIAMBAS
MARIA ADAMOPOULOU
ATHANASIOS STAMATELOPOULOS
ΚONSTANTINOS VACHLAS
SOTIRIOS PAPOULIAKOS
PAVLOS PANTOS
GEORGE AGROGIANNIS
ANDREAS C. LAZARIS
EFTHYMIOS KYRODIMOS
PERIKLIS TOMOS
 and 
NIKOLAOS KAVANTZAS
Cancer Diagnosis & Prognosis Jan-Feb; 5(1): 15-20 DOI: 10.21873/cdp.10406
Complete Response (CR) in a Previously-progressing Chronic Lymphocytic Leukemia (CLL) Patient Treated With Methionine Restriction in Combination With First-line Chemotherapy
SEI MORINAGA
QINGHONG HAN
KOHEI MIZUTA
BYUNG MO KANG
NORIO YAMAMOTO
KATSUHIRO HAYASHI
HIROAKI KIMURA
SHINJI MIWA
KENTARO IGARASHI
TAKASHI HIGUCHI
HIROYUKI TSUCHIYA
SATORU DEMURA
 and 
ROBERT M. HOFFMAN
Cancer Diagnosis & Prognosis Jan-Feb; 5(1): 21-26 DOI: 10.21873/cdp.10407
Prostate Cancer Patient With Lymph-node Metastasis Treated Only With Methionine Restriction Has Stable Disease for Two Years Demonstrated With PET/CT and PSMA-PET Scanning and PSA Testing
SEI MORINAGA
QINGHONG HAN
KOHEI MIZUTA
BYUNG MO KANG
NORIO YAMAMOTO
KATSUHIRO HAYASHI
HIROAKI KIMURA
SHINJI MIWA
KENTARO IGARASHI
TAKASHI HIGUCHI
HIROYUKI TSUCHIYA
SATORU DEMURA
 and 
ROBERT M. HOFFMAN
Cancer Diagnosis & Prognosis Jan-Feb; 5(1): 27-31 DOI: 10.21873/cdp.10408
Tumor β-Catenin Expression Associated With Poor Prognosis to Anti-PD-1 Antibody Monotherapy in Non-small Cell Lung Cancer
SATOSHI MUTO
YUKI OZAKI
HIKARU YAMAGUCHI
MASAYUKI WATANABE
NAOYUKI OKABE
YUKI MATSUMURA
KAZUYUKI HAMADA
 and 
HIROYUKI SUZUKI
Cancer Diagnosis & Prognosis Jan-Feb; 5(1): 32-41 DOI: 10.21873/cdp.10409
Effect of Diabetes on Outcomes in Patients With Incurable/Unresectable and Advanced/Recurrent Colorectal Cancer Receiving mFOLFOX6
MAI IKEMURA
MASAKI HIRABATAKE
MEGUMI ABURAYA
HIROAKI IKESUE
HISATERU YASUI
NOBUYUKI MUROI
 and 
TOHRU HASHIDA
Cancer Diagnosis & Prognosis Jan-Feb; 5(1): 42-48 DOI: 10.21873/cdp.10410
Clinical and Pathological Analysis of Perianal Paget’s Disease: A Case Report and Review of 89 Cases
KAE ISHII
HIDEKAZU TAKAHASHI
HIROMI TSUJI
TAKAYOSHI ISHIHARA
YUKA IWAMI
WATSAPOL JUAVIJITJAN
MITSUKI YOKOTA
SHOHEI TAKAICHI
MASAKATSU PAKU
KAZUYA IWAMOTO
TOMOFUMI OHASHI
YUJIRO NAKAHARA
TADAFUMI ASAOKA
CHU MATSUDA
KAZUHIRO NISHIKAWA
 and 
TAKESHI OMORI
Cancer Diagnosis & Prognosis Jan-Feb; 5(1): 49-55 DOI: 10.21873/cdp.10411
Current Status of Sequential Treatment for Castration-resistant Prostate Cancer: A Retrospective Analysis
KAZUHIKO OSHINOMI
TOSHIKI MUGITA
TATSUKI INOUE
MADOKA OMIZU
MOTOKI YAMAGISHI
YOSHIHIRO NAKAGAMI
MASAKAZU NAGATA
HIDEAKI SHIMOYAMA
MICHIYA OTA
JUN MORITA
HARUAKI SASAKI
EIJI MATSUBARA
KATSUYUKI SAITO
KOHZO FUJI
MASASHI MORITA
 and 
TAKASHI FUKAGAI
Cancer Diagnosis & Prognosis Jan-Feb; 5(1): 56-61 DOI: 10.21873/cdp.10412
Remnant Stomach Influx Reduces Esophageal Reflux and Malnutrition After Proximal Gastrectomy With Double Tract Reconstruction
RYOHEI NISHIGUCHI
TAKESHI SHIMAKAWA
SHINICHI ASAKA
MASAKO OGAWA
KENTARO YAMAGUCHI
MINORU MURAYAMA
MASANO SAGAWA
KOTARO KUHARA
TAKEBUMI USUI
HAJIME YOKOMIZO
 and 
SHUNICHI SHIOZAWA
Cancer Diagnosis & Prognosis Jan-Feb; 5(1): 62-71 DOI: 10.21873/cdp.10413
Impact of Changes in Psoas Muscle Index on Prognosis in Patients With Colorectal Liver Metastases
YUKINA KUSUNOKI
TATSUNARI FUKUOKA
ATSUSHI SUGIMOTO
GEN TSUJIO
KEN YONEMITSU
YUKI SEKI
HIROAKI KASASHIMA
MASATSUNE SHIBUTANI
 and 
KIYOSHI MAEDA
Cancer Diagnosis & Prognosis Jan-Feb; 5(1): 72-82 DOI: 10.21873/cdp.10414
Treatment Strategies in Elderly Patients With Operable, Hormone Receptor-negative Breast Cancer
TATSUHIKO IKEDA
MISUZU TAKEDA
MUNECHIKA TSUJI
SOTARO AKATSUKA
 and 
DAISUKE OTA
Cancer Diagnosis & Prognosis Jan-Feb; 5(1): 83-88 DOI: 10.21873/cdp.10415
Prognostic Value of the Modified Cachexia Index in Colorectal Cancer Patients Undergoing Curative Surgery
TSUYOSHI NISHIYAMA
MASATSUNE SHIBUTANI
HIDEKI TANDA
YUKI SEKI
SHINICHIRO KASHIWAGI
HIROAKI KASASHIMA
TATSUNARI FUKUOKA
 and 
KIYOSHI MAEDA
Cancer Diagnosis & Prognosis Jan-Feb; 5(1): 89-94 DOI: 10.21873/cdp.10416
Association of Pretreatment Albumin-bilirubin Grade With Hepatotoxicity and Efficacy in EGFR-TKIs Therapy for NSCLC
HIROKI ARIHARA
HIDETSUGU NAGAMATSU
YUJI HAYAKAWA
HIROKI MASE
TOMOYUKI ARAYA
 and 
TOSHIYUKI KITA
Cancer Diagnosis & Prognosis Jan-Feb; 5(1): 95-104 DOI: 10.21873/cdp.10417
Outcomes of Combined Atezolizumab Plus Chemotherapy in Non-small Cell Lung Cancer Patients in Clinical Practice
TAKESHI NUMATA
RYOTA NAKAMURA
TOSHIHIRO SHIOZAWA
HIROKO WATANABE
SHINICHIRO OKAUCHI
GEN OGARA
TOMOHIRO TAMURA
NORIHIRO KIKUCHI
KUNIHIKO MIYAZAKI
SHIGEN HAYASHI
TAKAAKI YAMASHITA
KOICHI KURISHIMA
MASAHARU INAGAKI
HIROAKI SATOH
TAKAYUKI KABURAGI
TAKEO ENDO
 and 
NOBUYUKI HIZAWA
Cancer Diagnosis & Prognosis Jan-Feb; 5(1): 105-114 DOI: 10.21873/cdp.10418
The Global Immune-Nutrition-Information Index (GINI) Is an Independent Prognostic Factor for Esophageal Cancer Patients Who Receive Curative Treatment
SOSUKE YAMAMOTO
TORU AOYAMA
YUKIO MAEZAWA
ITARU HASHIMOTO
RYUKI ESASHI
KEISUKE KAZAMA
KOJI NUMATA
MAMORU UCHIYAMA
AYAKO TAMAGAWA
AYA SAITO
 and 
NORIO YUKAWA
Cancer Diagnosis & Prognosis Jan-Feb; 5(1): 115-121 DOI: 10.21873/cdp.10419
Clinical Outcomes of Micropapillary Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy
KAZUMASA JOJIMA
AKINORI MINATO
HIROTSUGU NOGUCHI
YOJIRO TSUDA
 and 
NAOHIRO FUJIMOTO
Cancer Diagnosis & Prognosis Jan-Feb; 5(1): 122-126 DOI: 10.21873/cdp.10420
Successful Salvage of Four Cases of Unresectable Papillary Thyroid Cancer Following Lenvatinib Administration
KODAI TSUCHIDA
KIYOTO SHIGA
KATSUNORI KATAGIRI
DAISUKE SAITO
SHIN-ICHI OIKAWA
AYA IKEDA
JUN MIYAGUCHI
 and 
TAKAHIRO KUSAKA
Cancer Diagnosis & Prognosis Jan-Feb; 5(1): 127-131 DOI: 10.21873/cdp.10421
Prognostic Significance of Lymphocyte-to-Monocyte Ratio in Patients With Unresectable Biliary Tract Cancer Undergoing Systemic Chemotherapy
HIDEO SUZUKI
AKIFUMI KUWANO
JUNRO TAKAHIRA
KOSUKE TANAKA
MASAYOSHI YADA
 and 
KENTA MOTOMURA
Cancer Diagnosis & Prognosis Jan-Feb; 5(1): 132-137 DOI: 10.21873/cdp.10422